713 related articles for article (PubMed ID: 19962348)
1. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J
Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348
[TBL] [Abstract][Full Text] [Related]
2. Complement-mediated cytotoxicity of antibodies to the GABA(B) receptor.
Batocchi AP; Della Marca G; Frisullo G
Lancet Neurol; 2010 Apr; 9(4):343; author reply 343-4. PubMed ID: 20298957
[No Abstract] [Full Text] [Related]
3. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
[TBL] [Abstract][Full Text] [Related]
5. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.
Lai M; Huijbers MG; Lancaster E; Graus F; Bataller L; Balice-Gordon R; Cowell JK; Dalmau J
Lancet Neurol; 2010 Aug; 9(8):776-85. PubMed ID: 20580615
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of anti-Ma2-associated encephalitis.
Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
[TBL] [Abstract][Full Text] [Related]
7. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.
Lai M; Hughes EG; Peng X; Zhou L; Gleichman AJ; Shu H; Matà S; Kremens D; Vitaliani R; Geschwind MD; Bataller L; Kalb RG; Davis R; Graus F; Lynch DR; Balice-Gordon R; Dalmau J
Ann Neurol; 2009 Apr; 65(4):424-34. PubMed ID: 19338055
[TBL] [Abstract][Full Text] [Related]
8. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.
Graus F; Saiz A; Lai M; Bruna J; López F; Sabater L; Blanco Y; Rey MJ; Ribalta T; Dalmau J
Neurology; 2008 Sep; 71(12):930-6. PubMed ID: 18794496
[TBL] [Abstract][Full Text] [Related]
9. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis.
Mundiyanapurath S; Jarius S; Probst C; Stöcker W; Wildemann B; Bösel J
J Neuroimmunol; 2013 Jun; 259(1-2):88-91. PubMed ID: 23628208
[TBL] [Abstract][Full Text] [Related]
10. Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of γ-aminobutyric acid type B receptor autoimmunity.
Kruer MC; Hoeftberger R; Lim KY; Coryell JC; Svoboda MD; Woltjer RL; Dalmau J
JAMA Neurol; 2014 May; 71(5):620-3. PubMed ID: 24590315
[TBL] [Abstract][Full Text] [Related]
11. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
[TBL] [Abstract][Full Text] [Related]
12. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.
Boronat A; Sabater L; Saiz A; Dalmau J; Graus F
Neurology; 2011 Mar; 76(9):795-800. PubMed ID: 21357831
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis.
Kim TJ; Lee ST; Shin JW; Moon J; Lim JA; Byun JI; Shin YW; Lee KJ; Jung KH; Kim YS; Park KI; Chu K; Lee SK
J Neuroimmunol; 2014 May; 270(1-2):45-50. PubMed ID: 24662003
[TBL] [Abstract][Full Text] [Related]
14. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
[TBL] [Abstract][Full Text] [Related]
16. Anti-GABAB receptor encephalitis associated with combined small cell lung carcinoma.
Chao CH; Chu CC; Wei YC; Tseng JR; Chang HS
J Neuroimmunol; 2021 Nov; 360():577705. PubMed ID: 34478989
[TBL] [Abstract][Full Text] [Related]
17. GABA-B Receptor Encephalitis Triggered by Enterovirus Encephalitis in a Patient With Small Cell Lung Cancer: A Case Report.
Kim SH; Kim W
Neurologist; 2020 Jul; 25(4):106-108. PubMed ID: 32618841
[TBL] [Abstract][Full Text] [Related]
18. Isolated seizures are a common early feature of paraneoplastic anti-GABA
Maureille A; Fenouil T; Joubert B; Picard G; Rogemond V; Pinto AL; Thomas L; Ducray F; Quadrio I; Psimaras D; Berzero G; Antoine JC; Desestret V; Honnorat J
J Neurol; 2019 Jan; 266(1):195-206. PubMed ID: 30460450
[TBL] [Abstract][Full Text] [Related]
19. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
